Products – Product Pipeline
New product development strategies focus on:
- Improving customer experience
- Improving margins
- The treatment of added disorders
- Developing additional products within the Industrial Ingredient business
Critical to customer acquisition and retention, is the ability to provide our innovative products in a variety of customer acceptable flavours, with options for consumption preferences and convenience.
Our development team uses customer feedback and emerging food and beverage trends to develop flavour profiles, refine the mouthfeel experience and explore new ways to deliver the product benefits in tablet, pre-mix and beverage forms suitable for at-home or on-the-go consumption.
We also have a policy to minimise the lifetime impact on the environment – this is both a MediKane policy – and a need from customer feedback over several years.
MediKane’s scientific research team in association with Macquarie University, won a $2.1m 3 - year ARC grant to analyse the medical basis of the health benefits that the NutriKane technology and products deliver. Based on this research, our pipeline for new product development will expand on our foundation products to provide natural health management options for other lifestyle concerns. The new products all follow current consumer requirements of:
The new products all follow current consumer requirements of:
- Minimally processed
- Gluten Free
- Safe - no adverse side effects
- Safe - cannot be overdosed
- Safe - for both children and the elderly
- Can be consumed by customers that also use pharmaceutical treatments.
Products developed and awaiting appropriate launch dates including:
A retail version of NutriKane+ for optimising regularity with its key claims being:
NutriKane R will be a ready-to-drink product. It will have a different formulation and be suitable for regular and consistent use in the home.
MediKane’s vision is to develop a product for use by people with Type 1 diabetes. In Australia, MediKane will seek to acquire Therapeutic Goods Administration (TGA) approval for this natural, plant-based alternative to pharmaceutical drugs.
For Chronic Pain